Masia.vc
VC Fund
Masia.vc is a venture capital firm that seeks to invest in pre-seed and seed companies in GenAI.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Masia.vc invests in
Stages Masia.vc invests in
Countries Masia.vc invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Pepe Segura
|
|||
Investment Focus
Industry
- Software 1 (11%)
- Biopharma 1 (11%)
- Health Care 1 (11%)
- Life Science 1 (11%)
- Therapeutics 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Pepe Segura
Co-founder & Partner
|
Co-founder & Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ENERA TECHNOLOGIES LTD
|
Enera provides hybrid AI and human Level 1 support services for electric vehicle charging networks. The company focuses on handling driver support contacts across channels such as phone, SMS, email, and chat for charge point operators. Its system integrates with charge point management systems, ticketing tools, and CRM platforms to receive, triage,and troubleshoot issues like starting or stopping a charge, payment failures, RFID problems, connector faults, and basic account or tariff questions. Enera uses AI agents with human-in-the-loop escalation to in-house electric vehicle experts to resolve incidents and route only higher-level cases to internal Level 2 teams. The service aims to reduce escalations, shorten wait times, and maintain charger availability while fitting into existing operational workflows. Enera is positioned within the energy technology and business software sectors, with an emphasis on EV infrastructure support operations. | $2M / Pre-Seed / Jun 11, 2026 | |
Opereit
|
Opereit believes that their AI agents can become a vital tool for logistics operators, transforming a neglected area of loss into a source of recovered revenue. | $2.5M / Pre-Seed / Jun 03, 2026 | |
mafer AI
|
Mafer AI is an AI company that organizes and uses technical knowledge from lab data, documents, and expert insights to improve product development and decision-making. It develops AI-native operating system designed for research and development teams in formulation-driven industries such as chemicals, food, cosmetics, fragrances, and personal care. | $2.3M / Pre-Seed / May 29, 2026 | |
Overwatch AI
|
Overwatch AI provides an offline-capable AI assistant designed for frontline teams in critical environments. It allows users to access operational guidance from manuals and SOPs using natural language queries, even without internet connectivity. The platform supports use cases in industries such as aviation, manufacturing, energy, and maritime,with secure on-premises deployment. | $1.5M / Pre-Seed / May 20, 2026 | |
|
Tolemy Bio
|
Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies. The company focuses on precision-engineered, custom cell culture media for cell and gene therapies and biologics. Its platforms use artificial intelligence and machine learning to map how nutrients and signals influence cells. TolemyBio supports cell therapy innovators with data-driven media design and process control. Its solutions aim to improve critical quality attributes and manufacturability for advanced therapeutic products. | $1.6M / Pre-Seed / May 12, 2026 | |
Pollen
|
Pollen is developing a universal battery-swapping network for mopeds and motorcycles, enabling riders to quickly exchange depleted batteries for fully charged ones, reducing downtime and supporting efficient, scalable electric mobility in urban environments. | $3.8M / Seed / May 07, 2026 | |
BASE4 Biosciences
|
BASE4 Biosciences is a precision health firm developing a new layer of preventive medicine. | $850.8K / Pre-Seed / Apr 22, 2026 | |
Traza
|
Traza builds autonomous AI agents for procurement and supply chain automation in manufacturing and construction. | $2.1M / Pre-Seed / Apr 15, 2026 | |
Galtea
|
Galtea offers software that enables developers and companies to rigorously test AI agents prior to deployment. The platform automatically generates scenarios tailored to specific use cases, while applying customized metrics to pinpoint errors and evaluate performance. This helps teams thoroughly assess how their AI systems operate across diverseconditions. | $3.2M / Seed / Mar 25, 2026 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Masia.vc invest in?
Masia.vc invests primarily in Software, Biopharma and Health Care startups, most often at Pre-Seed stage. Most of the 9 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Masia.vc?
Public channels for Masia.vc include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Masia.vc?
The team at Masia.vc includes Pepe Segura (Co-founder & Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
